Getting leptin levels 'just right' may provide cardiovascular protection

October 29, 2018, Medical College of Georgia at Augusta University
Drs. Thiago Bruder do Nascimento and Eric Belin de Chantemele Credit: Phil Jones, Senior Photographer, Augusta University

Like that famous bowl of porridge, when leptin levels are "just right" they help protect our cardiovascular health, scientists say.

This satiety hormone, made primarily by fat , is best known for telling our brains we are full. In obesity, levels are high but the brain becomes resistant to its message and the cardiovascular system instead comes under attack.

Too little fat and leptin can create a similar cardiovascular risk.

"We need to restore the leptin balance and then we will see its cardiovascular protection," says Dr. Thiago Bruder do Nascimento, postdoctoral fellow in the Vascular Biology Center at the Medical College of Georgia at Augusta University.

"We think we already have good information that at the right level, leptin protects the cardiovascular system," says Dr. Eric Belin de Chantemele, MCG physiologist and Bruder do Nascimento's mentor.

If their studies continue to confirm this, it could point the way toward opening up leptin therapy to a wider range of patients.

Bruder do Nascimento recently received a $965,370 National Institutes of Health K99 grant for postdocs that's enabling those studies.

They are using a model of extreme leptin deficiency resulting from an extreme fat shortage you can be born with or acquire, called lipodystrophy. While congenital lipodystrophy is rare, infectious conditions like measles or pneumonia, autoimmune diseases, injury, even repeated use of the same injection site for something like daily insulin, can result in acquired lipodystrophy. So can the older but effective antiretroviral therapies for human immunodeficiency virus, or HIV.

Despite the fact that leptin therapy has been prescribed for patients with lipodystrophy since 2014 and the amount given is low, the impact on their cardiovascular system remains unknown, Belin de Chantemele notes.

To create the acquired model, Bruder do Nascimento used a single drug, Ritonavir, long used as an HIV therapy booster, particularly for patients who might not take their medicines as prescribed. He's finding that after taking Ritonavir for just four weeks, mice develop lipodystrophy and severe vascular dysfunction.

Just one week of leptin therapy reduced the vascular inflammation and significantly improved function, Bruder do Nascimento says. Now they want to know whether it's a lasting benefit.

They also are learning more about how low leptin hurts the cardiovascular system by looking further at its effect on the single layer of endothelial cells that line our blood vessels.

The cacophony of problems endothelial cells develop just may start with oxidative stress, a byproduct of oxygen use that is damaging at high levels; resulting inflammation; and an impaired ability to help blood vessels relax.

They have evidence that reduced availability of leptin to endothelial cells means the cells help produce less nitric oxide that enables blood vessel relaxation. They've shown lipodystrophy also increases oxidative stress, including increased expression of the Nox1 enzyme, which produces the unhealthy byproduct, and reduced PPARy, a receptor involved in good things like reducing bad cholesterol and lipid levels whose loss is associated with higher blood pressure and vascular disease.

The higher oxidative stress produces inflammation, which attracts more and more inflammation.

Both the and the that form the outer wall of blood vessels have chemokine receptors, which are stimulated by the and which help attract those immune cells.

"If you have an inflamed blood vessel, you have activation of this receptor and this receptor sends the message that we have to have more immune cells here," Bruder do Nascimento says. The immune cells, in turn, secret substances called cytokines, which induce endothelial dysfunction and damage.

They have watched leptin therapy normalize the unhealthy scenario. When they removed what they consider a primary instigator by scavenging for reactive oxygen species with drugs like a Nox1 inhibitor, it also restored endothelial cell function and reduced inflammation.

The MCG scientists have evidence that in blood vessels, leptin somehow decreases chemokine receptors and the ligands that activate them and helps stop the flood of immune cells to the scene. It has the added benefit of decreasing glucose and lipid levels, both of which are cardiovascular risks when high. But in this scenario, decreasing glucose, for example, does not appear to directly result in cardiovascular protection, Bruder do Nascimento notes.

"The effect of leptin directly on the vessel seems to be preventative," he says.

Now they are learning more about how and really if leptin controls immune cells moving into . Interestingly leptin deficient mice are actually more susceptible to infection despite the onslaught of immune cells, Belin de Chantemele says. "It's turning up inflammation, macrophages and your T cells but in a bad way," he adds of leptin's duplicitous role.

A possible problem with leptin therapy could be that the mice, previously unaccustomed to higher , actually end up losing weight because of increased signaling to their brain that they are full. Ironically, while obese individuals become insensitive to leptin's satiety signal those with less fat, and less leptin, are more sensitive to it, Belin de Chantemele notes.

Explore further: Too little fat is bad for cardiovascular health and leptin therapy may help

Related Stories

Too little fat is bad for cardiovascular health and leptin therapy may help

October 16, 2017
We know that too much body fat is generally bad for our cardiovascular system, and now scientists are learning more about how too little fat yields some of the same damage.

Satiety hormone leptin plays a direct role in cardiovascular disease in obesity

October 7, 2015
While high levels of the satiety hormone leptin don't help obese individuals lose weight, they do appear to directly contribute to their cardiovascular disease, researchers report.

Hypertensive women may benefit most from drugs that directly block the action of the hormone aldoste

August 2, 2017
When women are hypertensive their physicians should consider measuring their level of aldosterone, a hormone that at high levels damages the cardiovascular system, scientists say.

Scientists work to protect obese, younger women from cardiovascular work

March 14, 2018
Obese, premenopausal women can lose the innate protection from cardiovascular disease that their youth and estrogen are believed to afford, and scientists want to know how.

Satiety in 3-D

October 11, 2018
Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain. That is not the case, as a group of scientists from Helmholtz ...

Researcher works to block the blood-vessel dysfunction that occurs in diabetes

December 3, 2014
One of diabetes' dangerous consequences is dysfunction of the single-cell layer that lines our blood vessels.

Recommended for you

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

Genetic analysis links obesity with diabetes, coronary artery disease

November 16, 2018
A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published ...

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.